25.500
−1,92%
2026-10-01
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -21.6% | -11.4% | 1 / 3 | -0.7% | -0.83 pp | -0.27 pp | +21.9% | 0.26 | 9.16 | 128 | −0,7% | 25,4 | −2,1% | 9.16 | 12.60 | −27,3% |
| Pts | 0 | 0 | 4 | 0 | 4 | 4 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 25.500 (close price on 2026-10-01)EPS (TTM): 2.785
Financial charts
1.Revenue & growth
VND bn128Q3/26
1.Revenue & growth
VND bn128Q3/26
2.Profit & growth
VND bn25,4Q3/26
3.Profit mix (Penman)
VND bn100Q3/26
4.Margins & cost structure
%23.6%Q3/26
5.Returns & cash cycle
% · days19.9%Q3/26
6.Earnings quality & cash
VND bn171Q3/26
7.Asset structure
VND bn613Q3/26
8.Funding & debt health
VND bn · times613Q3/26
9.Revenue backlog
VND bn1,73Q3/26
10.Valuation
times · %10,1×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %710Q3/26
Adjusted EPS growth, latest quarter
-21.6%
Average adjusted EPS growth, 3 quarters
-3.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26